Phio Pharmaceuticals - Warrants (21/12/2021) Accounts Payable

As of the most recent data (June 2026), PHIOW shows a accounts payable of $900K. That compares with $240K in the prior-year period — up 283.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PHIOW's accounts payable is now $900K (was $240K) — a 283.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Phio Pharmaceuticals - Warrants (21/12/2021) is outperforming or lagging.

Tracking PHIOW's accounts payable over time shows whether Phio Pharmaceuticals - Warrants (21/12/2021) is scaling, shrinking, or reshaping that part of the business. The current reading is $900K That compares with $240K in the prior-year period — up 283.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Phio Pharmaceuticals - Warrants (21/12/2021)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $900K) with ownership activity and broader fundamentals.

Phio Pharmaceuticals - Warrants (21/12/2021)'s accounts payable is $900K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.